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Abstract
Extracellular vesicles (EVs) are one of several tools that cells
use to communicate with each other. This communication
is facilitated by a number of surface-associated proteins and
the cargo of the vesicles. For several cancer types, the amount
of EVs is  observed to be up-regulated in patients com‐
pared  to  healthy  individuals,  possibly  signifying  the
presence  of  an  aberrant  process.  The  hypoxia-induced
release of EVs from cancer cells has been hypothesized to
cause the malignant transformation of healthy recipient
cells.
In this study, the phenotype of cells and EVs from the
ovarian cancer cell lines, COV504, SKOV3, and Pt4, were
quantified and analysed under normoxic and hypoxic
conditions. It was shown that both cells and EVs express
common markers and that the EV phenotype varies more
than the cellular phenotype. Additionally, cells subjected
to 24 hours of hypoxia compared to normoxia produced
more EVs.
The phenotyping of EVs from cancer cell lines provides
information about their molecular composition. This
information may be translated to knowledge regarding the
functionality of EVs and lead to a better understanding of
their role in cancer.
Keywords Extracellular Vesicles, Ovarian Cancer Cell
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1. Introduction
The interest in extracellular vesicles (EVs) has increased
immensely over the last few years. EVs are believed to be
an important component of extracellular communication
[1], although, their exact functions are not fully understood.
In humans, EVs are a heterogeneous population of mem‐
brane-enclosed vesicles that are released into the extracel‐
lular space by most cell types. They have been shown to be
involved in a variety of important physiological and
immunological processes [2–4]. They may also be involved
in the progression of pathological conditions such as cancer
[5,6]. EVs are often divided into three major subpopula‐
tions based on their size, biogenesis and molecular compo‐
sition, namely exosomes, microvesicles and apoptotic
bodies [1,7–11]. Even though the molecular composition of
these three subsets of EVs is different, several markers
overlap. These markers are not ubiquitously expressed on
EVs but are found on a majority of them [7,9,12]. So far,
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identification of a specific marker that, with certainty, can
distinguish between the three subsets has not been discov‐
ered. Along with these proteins, the molecular composition
depends on the cellular source, often mirroring the parent
cell [13,14]. Notably, recent data suggest that the phenotype
of EVs is specific and well-regulated, and not just the result
of a casual sampling of molecules from the parent cell [15].
The current study investigates the subset of EVs that
presents CD9, CD63 and CD81.
A large number of studies have reported that EVs are
involved in the development and progression of cancer.
Their role in cancer is emphasized by the fact that the
release of EVs is accelerated in tumour cells, as demon‐
strated by in vitro studies, as well as by the large amount of
EVs or EV-like structures that can be purified from plasma,
ascites and pleural effusions of cancer patients [16–18].
Tumour-derived EVs have been reported to both stimulate
and suppress tumour-specific and non-specific immune
responses. This capacity may be explained by the similarity
of the protein composition of EVs and the parent cell type,
which suggests that the tumour-derived EVs contain
tumour-specific antigens that can stimulate or inhibit an
anti-tumour response [17–22].
Hypoxia is one of many factors that are believed to be
important for the maintenance of the tumour milieu.
Hypoxic regions are observed in most solid tumours [23,24]
and numerous factors involved in the promotion of
metastasis have been described to be induced by hypoxia
[25–28]. Furthermore, it has been reported that patients
with hypoxic primary tumours developed more metastasis
than patients with less hypoxic tumours [29,30]. Hence,
hypoxia is an important factor for the tumour milieu, as
well as for the metastatic processes. Taken together, it
seems that both hypoxia and tumour-derived EVs can play
important roles at multiple stages of tumour pathogenesis,
ranging from suppressing the anti-tumour responses to
facilitating the formation of a suitable microenvironment
in distant metastatic sites [31–35].
In this study, the cellular and EV phenotypes from the three
ovarian cancer cell lines, COV504, SKOV3 and Pt4, were
analysed. These three cell lines were chosen as they all
originally derive from ovarian cancer patients with
different tumour forms. Additionally, it was investigated
whether hypoxia could affect the phenotypes of cells and
EVs. For the cellular phenotype, a flow cytometric analysis
was used and five different markers were chosen on behalf
of their functional differences. Carboxic anhydrase IX
(CAIX) and Carboxic anhydrase XII (CAXII) are known as
hypoxic markers [36]. CD151 is known as an exosomal
protein associated with tumour progression. It enhances
cell motility, invasion and metastasis of cancer cells and is
over-expressed in many tumour types [37]. CD9 and CD81
are considered as general exosomal markers [9,12]. CD9 is
a cell surface glycoprotein known to complex with, e.g.,
integrins and other tetraspanins. It can modulate cell
adhesion and migration and trigger platelet activation and
aggregation [38]. CD81 is a surface glycoprotein that is
known to complex with integrins, and it is involved in
activation, co-simulation and differentiation [39]. For the
EV characterization, the protein microarray based EV
Array technique was applied to analyse and phenotype a
subset of these cell-derived vesicles, which carries the
general EV markers, CD9, CD63 and CD81 [40]. The
extensive phenotyping involved 31 markers that are related
to general EV proteins, cell-specific markers and a number
of cancer markers.
2. Materials and methods
2.1 Cell Cultures
SKOV3 (ATCC® HTB-77TM; ATCC, Manassas, VA, USA)
and Pt4 (primary cell line from ascites from an ovarian
cancer patient) were cultured in RPMI-1640 (Gibco, Life
Technologies, CA, USA) and supplied with 10% heat-
inactivated foetal calf serum (FCS) (Gibco), 100U/ml
penicillin and 0.1mg/mL streptomycin (Amplicon, Odense,
DK). COV504 (07071902-1VL, Sigma-Aldrich, St. Louis,
MO, VA) was cultured in Dulbecco´s Modified Eagle´s
Medium (DMEM) (Gibco) supplemented with 10% FCS,
100U/ml penicillin and 0.1mg/mL streptomycin.
The cells were cultured in 96-well plates in triplicates, with
a concentration of 1.25 x 105 cells/well in a total volume of
250µl. Media controls were included for each cell line.
Before supplementing the media with FCS, the FCS was
centrifuged at 100.000 x g for 24h, at 4°C (Ti45 rotor,
Beckman Coulter, Brea, USA) to deplete the EVs present in
the FCS. Under normoxic conditions, the cells were
cultured at 37°C in 5% (v/v) CO2 and with an atmospheric
O2 concentration. To induce hypoxia, the cells were
cultured at 37°C in 5% (v/v) CO2 and 1% (v/v) O2.
To determine the cell density, images of the different cell
lines were captured for each experimental condition, using
a FLOID Imaging Station (Life Technologies).
2.2 Phenotyping Cells by Flow Cytometry
The adherent cells were detached with trypsin (0.25%/
EDTA) (Gibco) for 10 min. For each cell line, cells from the
triplicate wells were pooled and washed once in cell media
and then twice in PBS (500 x g, 5min, room temperature
(RT)).
The following antibodies and reagents were used for flow
cytometry: Anti-CD151 (210127) and anti-CAXII (315602)
(R&D Systems, Minneapolis, MN, USA); 7-Aminoactino‐
mycin D (7AAD), anti-CD9-PerCP Cy5.5 (M-L13), control
mouse IgG1(k)-PerCP-Cy 5.5 (MOPC-21) and mouse
IgG1(k)-PE (MOPC-21) (BD Bioscience, San Jose, CA, USA);
Anti-CAIX (2D3) (Abcam, Cambridge, MA, USA); anti-
CD81-PE (1.3.3.22) (Ancell Corporation, MN, USA); and, as
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a secondary antibody, goat anti-mouse IgG1(k)-PE (Dako‐
Cytomation, Glostrup, DK).
For antibody staining, each sample contained 1.2 x 105 cells.
The cells were mixed with the relevant antibodies and
incubated for 30 min at RT in the dark. The cells were then
washed twice with PBS-BSA (0.5%, w/v) (500 x g, 5min, RT).
The cells that had incubated with unconjugated antibodies
were mixed with goat anti-mouse-PE and subsequently
incubated for 30 min at RT in the dark. Afterwards, the cells
were washed, resuspended in sheath fluid with 1%
paraformaldehyde (BD Bioscience) and analysed.
The acquisition of the stained cells was performed on a
FACSCanto II using FACSDivTM software (version 6.1.3, BD
Biosciences). The analysis of the data was carried out with
the FlowJo software (version 10.0.7, FlowJo LLC, Ashland,
OR, USA). The cellular phenotype for each marker was
determined for all events except cell debris by applying a
FSC/SSC gate that excludes debris. The negative isotype
controls were utilized to identify the positive events. For all
populations, the median fluorescence intensity (MFI) was
the statistical value of choice.
2.3 Preparation of EVs from Cell Cultures
For preparation of the EVs, the harvested cell culture
supernatant was centrifuged at RT for 10 min at 700 x g to
pellet the cells. The cell-free EV supernatants were supple‐
mented with protease inhibitors (Complete, EDTA-free,
Roche, DE, USA) and stored at -40°C until an analysis on
the EV-Array was carried out. There was no further
purification of the EVs prior to measuring on the EV Array.
2.4 Phenotyping Vesicles by the EV Array
Microarray printing was performed on a SpotBot® Extreme
Protein Edition Microarray Printer with a 946MP4 pin
(ArrayIt, CA, US). As positive and negative control, 100 µg/
mL of biotinylated human IgG and PBS with 5 % glycerol
was printed, respectively. Epoxy coated slides (75.6 mm x
25.0 mm; SCHOTT Nexterion, DE) were used and then left
to dry at RT overnight prior to further analysis.
For the EV Array, the following antibodies and protein
were used for capture: Annexin V (polyclonal), CAXII
(315602), CD13 (498001), CD82 (423524), CD142 (323514),
CD151 (210127), LAMP2 (H4A3), MUC1 (604804), TNF RI
(16803), TNF RII (22210), Tspan 8 (458811) (R&D systems);
AKAP3 (C-20), EpCam (O.N.277), Mucin 16 (X306), NY-
ESO-1 (E978), PLAP (8B6), TLR3 (TLR3.7) (Santa Cruz
Biotechnologies, TX, USA); Alix (3A9), CD63 (MEM-259),
CD309 (7D4-6), HLA ABC (W6/32) (Biolegend, CA, USA);
CAIX (2D3), Flotilin 1 (polyclonal), TSG101 (5B7), sTn (219)
(Abcam); CD9, and CD81 (LifeSpan BioSciences, Inc.
Seattle, WA, USA); EGFR (polyclonal), EGFRvIII (polyclo‐
nal) (Antibodies online.com (DE)); CD171 (polyclonal)
(Sigma-Aldrich); ICAM-1 (R6.5) (eBiosciences, CA, USA).
The bovine protein Lachtadhedrin (Haematologic Technol‐
ogies Inc, Vermont, USA) was used for capture along with
the listed antibodies. The antibodies and the protein were
printed in triplicates at 90 – 200 µg/mL diluted in PBS
containing 5% glycerol.
For the semi-quantification of EVs, the antibodies, CD9,
CD81 (LifeSpan Biosciences, Inc.) and CD63 (MEM-259)
(BioLegend), were printed in 18 repeated spots in a
mixture/cocktail of 100 µg/mL of each antibody diluted in
PBS and containing 5% glycerol.
For detection, a cocktail of the following biotinylated
antibodies were used: anti-CD9, -CD63 and -CD81 (Life‐
Span BioSciences, Inc.).
The catching and visualization of EVs, as well as the data
analysis, were performed as previously described in [40]
with minor modifications. In short, the slides were blocked
(50 mM ethanolamine, 100 mM Tris, 0.1% SDS pH 9.0) prior
to incubation with EV-containing cell supernatants (100µl
for phenotyping and 75µl for the semi-quantification). The
incubation was performed in Multi-Well Hybridization
Cassettes (ArrayIt, CA, USA) at RT for two hours, followed
by overnight incubation at 4 °C. After washing (PBS with
0.05% Tween®20), the slides were incubated with biotiny‐
lated detection antibodies (anti-CD9, -CD63, and -CD81)
(1:1500 in wash buffer). After washing, 30 min incubation
with Cy5-labelled streptavidin (Life Technologies) (1:1500
in wash buffer) was performed for detection. Prior to
scanning, the slides were first washed in washing buffer,
followed by MilliQ water, and dried using a Microarray
High-Speed Centrifuge (ArrayIt). Scanning and spot
detection were performed as previously described [40].
Briefly, the intensity of the antibody signal was calculated
by subtracting the mean of the background (without
sample/blank) from the mean of the triplicate antibody
spots. This signal was then divided by the signal from the
mean of the triplicate negative spots (without capture
antibody, with sample). The relative fluorescence intensity
was subsequently log2 transformed.
Graphs and statistics were made in GraphPad Prism (ver.
6.04, GraphPad Software, Inc. CA, USA) and Excel (ver.
2013, Microsoft, USA) and heatmaps were generated in
Genesis (ver. 1.7.6, IGB TU Graz, Austria). An unpaired t-
test was applied to test for differences between the semi-
quantitative measurements of EVs from the same cell line
subjected to two different conditions. Differences between
groups were considered statistically significant when p <
0.05. Unless otherwise specified, the data are presented as
mean ± SD.
3. Results
3.1 Cell Proliferation and Viability Following Hypoxic
Incubation
The three cancer cell lines, SKOV3, Pt4 and COV504, were
incubated under normoxic or hypoxic conditions. The cell
number and viability were determined for each cell line
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directly after thawing, and after 12 and 24 hours of cultur‐
ing (Table I). To investigate the oxygenic state of the cell
cultures, the cell lines, SKOV3 and COV504, were used as
examples and the expression of the glucose transporter,
GLUT1, and hypoxia-inducible factor, 1α (Hif-1α), were
analysed after culturing the cells under hypoxic or nor‐
moxic conditions for 24 hours. Data are presented in the
supplementary (S1). The proliferation and the viability of
SKOV3 and Pt4 did not change much over time or between
normoxic and hypoxic conditions. On the contrary,
COV504 showed a decrease in the viability under hypoxic
conditions, whereas the normoxic population retained a
higher viability after 24 hours. Furthermore, the cell count
of COV504 following 24 hours of incubation under hypoxic
conditions was only half the cell count observed in nor‐
moxic conditions.
3.2 Cellular Expression of Selected Surface Markers
The expression of CD9, CD81, CD151, CAIX and CAXII
were evaluated for the three cell lines, COV504, SKOV3 and
Pt4, followed by incubation at normoxic or hypoxic
conditions. The specific surface expression was determined
by flow cytometry directly following thawing after 12 and
after 24 hours. The expression of the five markers changed
marginally over time but, since most cultured cells need
time to adapt to changes and to a new environment, the
time point 24 hours is illustrated (Figure 1). The flow
cytometric analysis showed that the three cell lines clearly
expressed CD9, CD81 and CD151. SKOV3 also expressed
CAIX and CAXII (> 3 times the isotype MFI), whereas
COV504 and Pt4 expressed CAIX and CAXII (< 2 times the
isotype MFI). In addition, the effects of hypoxia on the
expression of the five cell surface markers were investigat‐
ed (Figure 1). After 24 hours of hypoxic conditions, the
median CD9 expression by COV504 was only half the MFI
of cells cultured under normoxic conditions, indicating that
CD9 expression by COV504 was affected by hypoxic
conditions. For all other markers, the expression on
COV504 remained unaffected by hypoxic conditions.
Similarly, the expression of the five markers on SKOV3 and
Pt4 were unaffected by hypoxic conditions.
3.3 Phenotyping of Cell-derived EVs
In addition to the cellular phenotypes, the phenotypes of
the cell-derived EVs found in the cell free supernatants
were determined. The EVs captured and measured by the
EV Array had a size of 30-300 nm (supplementary Figure
S2). This extensive phenotyping involved 31 markers
comprising general EV proteins, cell-specific markers and
a number of cancer markers. The effect of the oxygen levels
of the EV phenotype was evaluated over time. A summary
of the EV phenotypes can be seen in Figure 2. The heatmaps
demonstrate the phenotype of EVs from the three ovarian
cancer cell lines, subjected to either normoxic or hypoxic
conditions for 12 or 24 hours. Phenotypically, the EVs from
the three cell lines resembled each other and displayed
more or less the same markers under normoxic conditions.
The EVs derived from all three cell lines grown under
normoxic conditions expressed CD9, CD81, CD151, CD63,
Tspan8, CD82, ICAM-1, CAXII and CD142, whereas 16
markers were not detected. Only six markers (LAMP2, TNF
RII, PLAP, CD13, AKAP3 and Alix) showed a variable
expression. On the contrary, there were phenotypical
differences between the EVs derived from cells subjected
to hypoxic conditions. The EVs from COV504 and Pt4 had
a tendency to express their markers most strongly after 24
hours in normoxic conditions, whereas the EVs from
SKOV3 expressed their markers more strongly during
hypoxic conditions. In particular, this was observed with
CD9, CD81, CD151, CD63 and CD82. Furthermore, the EVs
from SKOV3 expressed considerably more markers
following 24 hours of hypoxia compared to the EVs from
COV504 and Pt4. When comparing the expression level
after only 12 hours, COV504 and Pt4 expressed their
markers most strongly under hypoxic conditions, whereas
SKOV3 expressed most of the markers most strongly under
normoxic conditions. Notably, when looking at the three
tetraspanins, CD9, CD63 and CD81, the EVs derived from














0h 8% 8% ----- ----- 125000 125000
12h 8% 13% 50% 50% 103750 115000
24h 11% 8% 100% 100% 140000 130000




0h 1% 1% ----- ----- 125000 125000
12h 20% 25% 30-40% 30-40% 62500 60000
24h 11% 29% 70-85% 70-80% 107500 52500
Pt4 Serous papillary
carcinoma ovary, stage 2,
ascites
0h 4% 4% ----- ----- 125000 125000
12h 13% 19% 50-60% 60-70% 117500 97500
24h 14% 14% 60-80% 70-80% 132500 122500
Table 1. Listed are the percentages of cell death (positive for 7AAD), percentages of cell density and cell count following harvest at the different time points
and conditions (normoxia and hypoxia) for the three ovarian cancer cell lines SKOV3, COV504 and Pt4
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all three cell lines did not express CD63 as strongly as the
other two known EV markers.
3.4 Comparison of EV and Cellular Phenotypes
In order to investigate whether the EV phenotype mirrored
the cellular phenotype, a comparison of the protein
composition was made. SKOV3 is used here as an example
but the other cell lines showed similar results (data not
shown). Figure 3 illustrates the relation between the
cellular and EV phenotypes (for the three markers, CD9,
CD81 and CD151) under normoxic and hypoxic conditions.
The amount of CD9, CD81 and CD151 presented on the EVs
varied if the cells were subjected to normoxic compared to
hypoxic conditions. The EVs displayed more pronounced
CD9 and CD81 after 12 hours of cell incubation in normoxic
Figure 1. The influence of hypoxia on the cellular phenotype of ovarian cancer cell lines. The different cell subsets were stained with antibodies against CAIX,
CAXII, CD151, CD81, CD9 and matched isotype controls and were analysed by flow cytometry. The overlays of the expression displayed by the cells subjected
to either normoxic or hypoxic conditions for 24 hours for the three cell lines, COV504, SKOV3 and Pt4, are displayed.
Figure 2. Phenotyping of EVs from ovarian cancer cell lines. The EV phenotypes were profiled using the EV Array printed with 31 different capture antibodies
and detected with a cocktail of antibodies against CD9, CD63 and CD81. The heatmaps of the phenotyping of EVs derived from COV504, SKOV3 and Pt4
subjected to either normoxic or hypoxic conditions for 12 or 24 hours.
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conditions compared to hypoxic conditions, whereas, after
24 hours, the presentation of CD9 was almost the same
under both conditions and CD81 was slightly more
expressed under hypoxic conditions. CD151 was more
presented on the EVs under normoxic compared to hypoxic
conditions for both 12 and 24 hours. On the contrary, there
were small differences in the cellular expression of CD9,
CD81 and CD151 observed over time with the two condi‐
tions, but the differences were not as defined as the ones
observed for the corresponding EVs.
Figure 3. Variations in EV and cellular phenotypes. The cellular phenotype
was analysed by flow cytometry, whereas the phenotype of the EVs was
determined with EV Array. The graphs display the ratio of the phenotypical
variations of the three markers, CD9, CD81 and CD151, between the EVs
(mean values) and cells (median values) from the cell line, SKOV3, after
either 12 or 24 hours under normoxic (N) or hypoxic (H) conditions. There
is one mean value (EVs) or median value (cells) for each of the three markers.
Therefore, no statistical measurements were performed.
3.5 The Production of EVs is Influenced by Various Factors
The EVs from the cell culture supernatants were harvested
at different time points and the relative amount of EVs were
estimated with the EV Array. This was achieved by
measuring the total fluorescence signal when antibodies
against the exosomal markers (CD9, CD63 and CD81) were
used both for the capture and detection of the EVs. Figure
4 displays the semi-quantitative measurement of the
relative amount of EVs derived from cells after 12 hours (A)
and 24 hours (B) for all three cell lines subjected to either
normoxic or hypoxic conditions. After 12 hours, the highest
amount of EVs was detected from the cells grown under
normoxic conditions, which was observed for all three cell
lines. In contrast, after 24 hours, the relative amount of EVs
considerably increased under hypoxic conditions.
From 12 hours to 24 hours, the relative amount of EVs
released by COV504 increased by 8% under normoxic
conditions, whereas, for the hypoxic conditions, the
increase was 46%. The corresponding values for Pt4 were
10% for normoxic conditions and 34% for hypoxic condi‐
tions. Finally, the relative amount of EVs from SKOV3
grown under normoxic conditions decreased by 8% and
increased by 28% under hypoxic conditions.
The results displayed in Figure 4 only include one cell
concentration. However, the same pattern was also
observed for a lower cellular concentration (data not
shown). As expected, a higher concentration of cells
produced more EVs than a lower concentration of cells,
even though a two-fold increase in cell concentration did
not result in a two-fold increase in the amount of cell-
derived EVs for any of the three cell lines. The influence
that the cell concentration had on the EV production was
also consistent for all three cell lines tested here (data not
shown).
4. Discussion
Analysing the protein composition of both EVs and their
parent cells is helpful to further understand the mechanism
of the EVs’ biogenesis and the functional roles that they
may play in the development of cancer [41]. Furthermore,
Figure 4. The EV production is influenced by several factors. The amount of EVs was semi-quantitatively estimated with the EV Array measuring the total
fluorescence signal when the EVs were captured, as well as detected with a cocktail of antibodies against CD9, CD63, and CD81. Each bar represents the
relative fluorescence intensity (mean ± SD) of each triplicate measurement on the EV Array. The relative amount of EVs produced by COV504, SKOV3 and
Pt4 under either normoxic (N) or hypoxic (H) conditions for 12 hours (A) and for 24 hours (B) is displayed.
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the proteomic profile of the cancer-derived EVs is impor‐
tant for discovering novel diagnostic biomarkers and
therapeutic targets. Cell culture supernatants have previ‐
ously been shown to contain EVs [42–44]. Analysing EVs
that are released from cell lines from a particular cancer
type offers the potential for the identification of EV
biomarkers that might be of diagnostic and prognostic
value, without the risk of mistaking the EV origin. This is
one advantage of using cell lines when looking into cancer
research. The EV phenotypes presented here can only
reflect the actual cell that they derive from, which makes it
easier to interpret the data. In an EV population obtained
from a heterogeneous cell population, there are several
cells that can act both as producers and recipients of EVs.
Prior to relating specific EV features to cancer or to other
pathological conditions, it is of great importance to gain
knowledge  about  EVs  in  general  and  in  cancer-like
conditions.
Several studies prior to this have phenotyped EVs but only
with one or a few protein markers and with extensive
purification steps, as reviewed in [7]. This has mostly been
done with Western blotting [45,46] and flow cytometry
[47,48].
The EV Array used for the investigation of the phenotypes
and quantification of EVs from the three ovarian cancer cell
lines is a microarray technique that was developed in our
laboratory. This technique is possible to perform without
prior purification of the samples.
In the present setup, the EV Array was optimized to analyse
the EV subset that carry the general exosomal markers,
CD9, CD63 and CD81, and have a size of approximately
30-100 nm.
Additionally, the EV Array provides an estimated relative
quantification of EVs in the samples by measuring the total
fluorescence signal when a cocktail of anti-CD9,-CD63 and
-CD81 is used to both capture and detect the EVs. Our data
indicate that cells from all three cell lines subjected to
hypoxic conditions for 24 hours have a tendency to produce
more EVs than cells subjected to normoxic conditions,
independent of cellular concentration and level of conflu‐
ence (Figure 3). Nevertheless, with these data, it could not
be decided whether a relatively higher amount of EVs or a
relatively higher amount of the markers, CD9, CD63 and
CD81, were produced under these conditions. However,
the measurement here is believed to be a semi-quantitative
measurement of the amount of EVs. This is based on the
fact that the phenotyping of EVs from both COV504 and
Pt4 display an increase in the level of CD9, CD63 and CD81
after 24 hours of cell incubation under normoxic conditions
compared to hypoxic conditions (Figure 2). Thereby, the
phenotyping displays the opposite situation of the semi-
quantification, which points to a higher amount of EVs
produced under hypoxia.
This observation was not surprising as it has earlier been
shown for rat osteoblasts [42], breast cancer cell lines [43,49]
and lung cancer cell lines [44]. Notably, there were more
cells after 24 hours of incubation in the cells subjected to
normoxic versus hypoxic conditions and, in the case of
COV504, even as much as double the amount of cells (Table
I). Moreover, the viability of most of the cells was the same
for both normoxic and hypoxic conditions. This could
indicate that the cells subjected to normoxia mostly focused
on proliferation, whereas the cells subjected to hypoxia
focused on EV release. This is in-line with another study
that reported that breast cancer cells exposed to hypoxia
increased their production of microvesicles, which stimu‐
lated invasion and metastasis of recipient breast cancer
cells [49]. SKOV3 already reached confluence before 24
hours, without altering their viability (see Table I) but,
despite this, they continued to produce EVs. Even though
these data do not conclude that the level of confluence is
without influence on the EV production, they may indicate
that cells do not stop producing EVs when they reach
confluence.
The fact that more EVs are produced per hour in the early
cultures, which are less confluent, might be explained by
the fact that cells produce EVs to communicate with each
other and the distance between cells are smaller in the cell
cultures with high confluence than in the ones with low
confluence. Therefore, they need more communicational
agents to communicate. It could also be because, as cell lines
are copies of themselves, the cells in such cultures only
communicate with themselves. Surely, the picture in vivo is
different and much more complex. This is probably the case
as all three cell lines are viable and grow just as well after
12 hours as after 24 hours. The point that more EVs can be
measured after 24 hours than after 12 hours only suggests
that EVs are not quickly degraded or taken up by the cells.
Instead, they stay in the culture for at least 24 hours.
Previously, EVs have been referred to as small copies of the
cells that they derive from but more and more evidence
show that this is not always the case. Proteins that are
highly expressed on EVs are not always expressed by the
cells (own observations for CD9, unpublished data). As EVs
often reflect the cells that they derive from, it is of interest
to see how different the expression levels are between EVs
and their parental cells. The data presented in this study
clearly show that the EVs are not exact copies of their
parental cells, even though the EVs reflect the cells that they
derive from. This is also consistent with data from Im H et
al., 2014, who show a phenotypical comparison of EVs and
cells from different ovarian cancer cell lines using flow
cytometry and a nano-plasmonic exosome assay [50].
The overall EV phenotype from the three ovarian cancer
cell lines show resemblances to each other, especially when
comparing the overall EV phenotype to other cancer cell
lines (data not shown). Even though all three cell lines show
resemblances to each other, they do so with variable
degrees. Different conditions influence the cell lines
differently and, therefore, must be said to express different
EV subsets. The different EV subsets that are seen between
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the three cell lines might be explained by the fact that the
cells that the EVs derive from come from different origins.
Furthermore, the different EV subsets that are seen and
how they vary due to hypoxic conditions and time could
indicate that they have different functions depending on
which cell type they derive from. These data clearly show
that hypoxia, in particular, has an effect on the expression
of proteins on EVs, even though there is no clear correlation
between the three cell lines. In particular, SKOV3 is highly
affected by hypoxia as it expresses considerably more
markers after 24 hours of hypoxic conditions compared to
normoxic conditions. Our data are supported by another
study that showed that vesicles released under hypoxia,
compared to vesicles released under normoxia, were
loaded with unique proteins that could enhance invasive‐
ness and induce microenvironment changes of the recipient
cells [51]. Furthermore, the expression level of the general
EV markers, CD9, CD63 and CD81, on EVs were clearly
affected by hypoxia. These data still support CD9 and CD81
as useful general EV markers but it should be noted that
the expression level of CD9 and CD81 can be affected by
several factors. Other interesting markers are MUC1, EGFR
and CD142, which are all highly related to cancer, particu‐
larly ovarian cancer. Firstly, many cancers, including
ovarian, overexpress MUC1 [52]. EGFR is reported to be
both increased in copy number and overexpressed in
serious ovarian carcinoma and is associated with a high
tumour grade, large residual tumour size, high prolifera‐
tion index and poor patient outcome [53]. Finally, CD142
regulates tumour cell proliferation and apoptosis, and can
promote tumour angiogenesis and metastasis in several
different cancers, as reviewed by Han X, et al. [54]. Detected
with the EV Array, all three markers were up-regulated in
EVs containing supernatant from SKOV3 cells subjected to
24 hours of hypoxia compared to normoxia. The multi‐
plexed protein profiling of EVs provides simultaneous
information about numerous possible biomarkers, which
increase the power of discrimination [55,56]. Thus, if
several of the proteins investigated in the present study
were combined, the likelihood of finding biomarkers,
which are of clinical relevance for early detection of ovarian
cancer, is greater.
In general, when looking at the five markers, CAIX, CAXII,
CD151, CD81 and CD9, the cellular phenotype was mostly
unaffected by time and oxygen level, whereas their
corresponding EVs were much more affected. The only
difference in the cellular expression of markers was seen
for CD9 on COV504 after 24 hours of either normoxic or
hypoxic conditions. This might be explained by the fact that
the hypoxic cell population had a considerable decreased
viability compared to the normoxic cell population. The
phenotyical differences seen between the cells and their
corresponding EVs cannot be explained by only one of the
factors (time, cellular concentration or oxygen level) but
rather, a combination of them. Even though there were
more EVs in the highest cellular concentration in the
hypoxic population after 24 hours, both COV504 and Pt4
displayed an increase in the level of most markers in the
normoxic population, whereas EVs from SKOV3 showed
the opposite. This might support the idea that EVs are used
by cells for fast and effective communication with their
surroundings. One study has even reported that EVs can
deliver a biologically active transcriptional factor, Hif-1α,
to a recipient cancer cell line [57].
To further stress the importance of investigating EVs and
their phenotypes for their potential role in cancer, a recently
published study showed that plasma exosomes from
cancer cells present a tumour-related proteomic profile.
Furthermore, the levels of bioactive molecules contained in
the exosomes of patients with solid tumours before surgery
are significantly higher than in exosomes from the same
patients after surgery [58].
Learning more about the role that EVs play in cellular
communication in healthy, and particularly under patho‐
logical conditions, will hopefully help to understand the
way that cancers develop and metastasize. The tumour
milieu has long been recognized as being important in the
way that cancers develop. Others have also shown that pH
and hypoxia can influence cell migration [35,49,51]. The
presented data emphasize the complexity of factors that
might influence the cellular and EV phenotype and thereby
the metastatic process.
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